5/16
07:32 am
dnth
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $40.00 price target on the stock.
Medium
Report
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $40.00 price target on the stock.
5/10
09:50 am
dnth
Rating for DNTH
Medium
Report
Rating for DNTH
5/10
09:50 am
dnth
Rating for DNTH
Medium
Report
Rating for DNTH
4/18
01:04 pm
dnth
Rating for DNTH
Low
Report
Rating for DNTH
4/18
01:04 pm
dnth
Rating for DNTH
Low
Report
Rating for DNTH
3/22
09:59 am
dnth
Rating for DNTH
Medium
Report
Rating for DNTH
3/22
09:59 am
dnth
Rating for DNTH
Medium
Report
Rating for DNTH